Biodegradable polymers: Emerging excipients for the pharmaceutical and medical device industries

Journal of Excipients and Food Chemicals

Volumn 4, Issue 4, 2013, Pages 126-157

  Patel, Bhavesh ^a   Chakraborty, Subhashis ^a  

^a Evonik Degussa India Pvt Ltd   (India)

Author keywords

Biodegradable polymers; Degradation; Drug eluting stents; Orthopedic implants; Sterilization; Tissue engineering

Indexed keywords

ACECLOFENAC; BIOPOLYMER; COPOLYMER; DICHLOROMETHANE; GANCICLOVIR; LEUPRORELIN; MICROSPHERE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYHYDROXYALKANOIC ACID; SMALL INTERFERING RNA;

ANGIOPLASTY; ATOMIC FORCE MICROSCOPY; BARE METAL STENT; BIOCOMPATIBILITY; BIODEGRADATION; CITRIC ACID CYCLE; CONTRACEPTIVE DEVICE; CORONARY ARTERY DISEASE; DEGRADATION KINETICS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG INDUSTRY; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; ENANTIOMER; ENCAPSULATION; EXTRACELLULAR MATRIX; FLOW KINETICS; FRACTURE HEALING; FREEZE DRYING; GEL PERMEATION CHROMATOGRAPHY; GENE THERAPY; HYDROPHILICITY; HYDROPHOBICITY; IMMUNOGENICITY; MEDICAL DEVICE; OBSTRUCTIVE CORONARY ARTERY DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PHASE SEPARATION; PHYSICAL CHEMISTRY; POLYMERIZATION; POROSITY; PROSTATE CANCER; PROTEOMICS; REVIEW; SCANNING ELECTRON MICROSCOPY; SUPERCRITICAL FLUID; SUTURE; SYNTHESIS; THERMODYNAMICS; THERMOGRAVIMETRY; TISSUE ENGINEERING; TOOTH IMPLANT; VISCOSITY; X RAY DIFFRACTION;

EID: 84891468356     PISSN: None     EISSN: 21502668     Source Type: Journal    
DOI: None     Document Type: Review

References (225)

1. ASTM FDA workshop on absorbable medical device. Presented by Byron Hayes. Nov 28, 2012. FDA White Oak campus, Maryland, USA. Available online at: http://www.fda.gov/downloads/MedicalDevices/N ewsEvents/WorkshopsConferences/UCM331546.p df
2. Huh KM, Cho YW, Park K. PLGA-PEG block copolymers for drug formulations. Drug Dev Delivery, 3: 5-12, 2003.
3. Middleton JC, Tipton AR. Synthetic biodegradable polymers as medical devices, Med. Plastics Biomater. Mag. 1998, 3, 30; Available online: http://www.devicelink.com/mpb/archive/98/03/0 02.html
4. Kolybaba M, Tabil L, Panigrahi S, Crerar WJ, Powell T, Wang B. Biodegradable polymers: past, present, and ASAE Annual Intersectional Meeting, North Dakota, USA, 2001.
5. Vroman I, Tighzert L. Biodegradable polymers. Materials, 2: 307-344, 2009.
6. Park JH, Mingli Y, Park K. Biodegradable polymers for microencapsulation of drugs. Molecules, 10: 146-61, 2005.
7. Premraj R, Mukesh D. Biodegradation of polymers. Indian J Biotechnol, 4:189-193, 2005.
8. Gupta AP, Kumar V. New emerging trends in synthetic biodegradable polymers-Polylactide: A critique. Eur Polym J, 43:4053-4074, 2007.
9. David K Platt. Book chapter. Biodegradable polymers market report. 2006. Smithers Rapra Limited, UK.
10. Edlund U, Aalbertsson AC. Degradable polymer microspheres for controlled drug delivery. Adv Polym Sci, 157:67-112, 2002.
11. Winzenberg G, Schmidt C, Fuchs S, Kissel T. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Adv Drug Deliver Rev, 56: 1453-1466, 2004.
12. Engineer C, Parikh J, Raval A. Review on hydrolytic degradation behavior of biodegradable polymers from controlled drug delivery system. Trends Biomater Artif Organs, 25:79-85, 2011.
13. San Jose, CA. 2012. Biodegradable polymers: A global business report. Available at: http://www.prweb.com/releases/biodegradablepoly mers/biopolymers/prweb9311798.htm (Last accessed 20 December 2012)
14. PLGA drug product market and development over the past three years. Source: IMS Health Midas, 2010 Available online at: www.imshealth.com (Last accessed 15 March 2013)
15. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol, 9:55-67, 2011.
16. Ghosh D, Pramanik P. Review article: low molecular weight biodegradable polymer based nanoparticles as potential delivery systems for therapeutics: the way forward? Int J Pharm Sci Drug Res, 2: 31-34, 2010.
17. Aarayne M, Sultana N. Review: Porous nanoparticles in drug delivery system. Pak J Pharm Sci, 19: 155-158, 2006.
18. Hughes GA. Review: Nanostructure-mediated drug delivery. Nanomedicine: NBM, 1: 22-30, 2005.
19. Dong, W., Multiparticulate drug delivery system for lipophilic drugs and macromolecule drugs, Chapter 1 in Dissertation Freie Universität Berlin, 2005, http://www.diss.fu-berlin.de/diss/receive/FUDISS _thesis_000000001718;jsessionid=B520D0FB61553 BA696869F51FD515426
20. Mishra N, Goyal AK, Khatri K, Vaidya B, Pliwal R, Rai S, Mehta A, Tiwari S, Vyas S, Vyas SP. Biodegradable polymer based particulate carrier(s) for the delivery of proteins and peptides. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 7: 240-251, 2008.
21. D'Souza SS, Deluca PP. Methods to assess in-vitro drug release from injectable polymeric particulate systems. Pharm Res, 23: 460-474, 2006.
22. Lakshmana PS, Shirwaikar AA, Shirwaikar A, Kumar A. Formulation and evaluation of sustained release microspheres of rosin containing aceclofenac. Ars Pharm, 50:51-62, 2009.
23. Odonell PB. Mcginity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Del Rev, 28: 25-42, 1997.
24. Li M, Rouaud O, Poncelet D. Review Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int J Pharm, 363: 26-39, 2008.
25. Sopimmath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Review: biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 70:1-20, 2001.
26. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials, 21: 2475-2490, 2000.
27. Jena KK, Nayak B. Biodegradable polymers (PLA and PLGA) based nanoparticles for protein and plasmid delivery. Thesis submitted to National Institute of Technology, Rourkela, 2011. Available at: http://ethesis.nitrkl.ac.in/2209/ (Last accessed 12 April 2013)
28. Giovagnoli S, Blasi P, Schoubben A, Rossi C, Ricci M. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm, 333: 103-111, 2007.
29. Herrmann J, Bodmeier R. The effect of particle microstructure on the somvastatin release from poly lactide microsphere prepared by w/o/w solvent evaporation method. J Control Release, 36: 63-71, 1995.
30. Crotts G, Park TG. Preparation of porous and nonporous biodegradable polymeric hollow microspheres. J Control Release, 35: 91-105, 1995.
31. Pandey R, Zahoor A, Sharma S, Khuller GK. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis, 83: 373-378, 2003.
32. Yoo HS. Preparation of biodegradable polymeric hollow microspheres using o/o/w emulsion stabilized by Labrafil®. Colloids Surf B: Biointerfaces, 52: 47-51, 2006.
33. Alireza M, Hashemein SK, Moghadam S, Atyabi F, Dinarvand R. Preparation and in-vitro evaluation of controlled release PLGA microparticles containing triptoreline. Iranian J Pharm Res, 9: 369-378, 2010.
34. Morita T, Sakamura Y, Horikiri Y, Yoshino H. Protein encapsulation into biodegradable microspheres by a novel s/o/w emulsion method using poly (ethylene glycol) as a protein micronization adjuvant. J Control Release, 69: 435-444, 2000.
35. Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 99: 271-280, 2004.
36. Duvvuri S, Janoria KG, Mitra AK. Development of a novel formulation containing poly (d, l-lactide-coglycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. J Control Release, 108: 282-293, 2005.
37. Herrmann J, Bodmeir R. The effect of particle microstructure on the somvastatin release from poly lactide microsphere prepared by w/o/w solvent evaporation method. J Control Release, 36: 63-71, 1995.
38. Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. The effect of formulation variables on the characteristics of insulin-loaded poly (lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B: Biointerfaces, 74: 340-349, 2009.
39. Ravi S, Peh KK, Darwis Y, Murthi K, Singh TRR, Mallikarjun C. Development and characterization of polymeric microsphere for controlled release protein loaded drug delivery system. Indian J Pharm Sci, 70: 303-309, 2008.
40. Cetin M, Atila A, Kadioglu Y. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium. AAPS PharmSciTech, 11: 1250-1256, 2010.
41. Monitera T, Ogura Y, Honda Y, Wada R, Hyon SH, Ikada Y. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. Invest Ophthal Visual Sci, 32:1785-1790, 1991.
42. Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T. Effects of process and formulation parameters on characteristics and internal morphology of poly (d, llactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm, 68: 214-223, 2008.
43. Hu Z, Liu Y, Yuan W, Wu F, Su J, Jin T. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids Surf B: Biointerfaces, 86: 206-211, 2011.
44. Galeska I, Kim TK, Patil SD, Bhardwaj U, Chattopadhyay D, Burgess D. Controlled release of dexamethasone from PLGA microspheres embedded within polyacid-containing PVA hydrogels. AAPS Journal, 7: E231-E240, 2005.
45. Luan X, Bodmeier R. Influence of the poly (lactideco-glycolide) type on the leuprolide release from in situ forming microparticle systems. J Control Release, 110:266-272, 2006.
46. Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release, 127:137-145, 2008.
47. Ertl B, Platzer P, Wirth M, GabOr F. Poly (D, Llactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J Control Release, 61: 305-317, 1991.
48. Wang J, Wang BM, Schwendeman SP. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly (d, llactide-co-glycolide) microspheres. Biomaterials, 25: 1919-1927, 2004.
49. Ibrahim MA, Ismail A, Fetouh MI, Gopfreich A. Stability of insulin during the erosion of poly (lactic acid) and poly (lactic-co-glycolic acid) microspheres. J Control Release, 106: 241-252, 2005.
50. Dutt M, Khuller GK. Liposomes and PLG microparticles as sustained release antitubercular drug carriers-an in vitro-in vivo study. Int J Antimicrob Agents, 18: 145-252, 2001.
51. Mi FL, Lin YM, Wu YB, Shyu SS, Tsai YH. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phaseseparation, degradation and release behavior. Biomaterials, 23: 3257-3267, 2002.
52. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials, 21: 2475-2490, 2000.
53. Basu SK, Kavitha K, Rupeshkumar M. Evaluation of ketorolac tromethamine microspheres by chitosan/gelatin B complex coacervation. Scientia Pharm, 78: 79-82, 2010.
54. Gangadhar CB, Sunder SR, Varma VK, Raju S, Kiran S. Formulation and evaluation of Indomethacin microspheres using natural and synthetic polymers as controlled release dosage forms. Int J Drug Discovery, 2:8-16, 2010.
55. Arunachalam A, Rathinaraj BM, Choudhary PK, Reddy AK, Fareedullah M. Preparation and evaluation of ofloxacin microsphere using natural gelatin polymer. Int J App Biology Pharm Technol, 1:61-67, 2010.
56. Sunitha S, Amareshwar P, Santosh KM, Chakravarti P. Study on effect of solvents & nonsolvents on microspheres of ciprofloxacin: coacervation phase separation. J Adv Sci Res, 1: 24-33, 2010.
57. Nihant N, Grandfils C, Jerome R, Teyssie P. Microencapsulation by coacervation of poly (lactideco-glycolide) IV. Effect of processing parameters on coacervation. J Control Release, 35: 117-125, 1995.
58. Jayan SC, Sandeep AV, Rifash M, Mareema C, Shamseera S. Design and in-vitro evaluation of gelatin microspheres of salbutamol sulphate. Hygeia, 1: 17-20, 2009.
59. Surendiran NS, Yuvaraj TV. Preparation and valuation of Ibuprofen microspheres by using coacervation phase separation technique. Int J ChemTech Res, 2: 1214-1219, 2010.
60. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: NBM, 6: 9-24, 2010.
61. Porta DG, Castalado F, Scognamiglio M, Parascandolla P, Reverchon E. Bacteria microencapsulation in PLGA microdevices by supercritical emulsion extraction. J Supercritical Fluids, 63: 1-7, 2012.
62. Wang Y, Pfeffer R, Dave R. Polymer encapsulation of fine particles by a supercritical antisolvent process. AIchE J, 51: 440-455, 2005.
63. Mohanraj VJ, Chen Y. Nanoparticles-a review. Tropical J Pharm Res, 5: 561-573, 2006.
64. Thote AJ, Gupta RB. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release. Nanomedicine: NBM, 1: 85-90, 2005.
65. Jordan F, Naylor A, Kelly CA, Howdle SM, Lewis A, Illum L. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: In vivo studies. J Control Release, 141: 153-160, 2010.
66. Salmaso S, Elvassore N, Bertucco A, Lante A, Caliceti P. Nisin-loaded poly-l-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity. Int J Pharm, 287: 163-173, 2004.
67. Kluge J, Fusaro F, Casas N, Mazzotti M, Muhrer D. Production of PLGA micro-and nanocomposites by supercritical fluid extraction of emulsions: I. Encapsulation of lysozyme. J Supercritical Fluids, 50: 327-335, 2009.
68. Lee LY, Wang CH, Smith KA. Supercritical antisolvent production of biodegradable micro-and nanoparticles for controlled delivery of paclitaxel. J Control Release, 125: 96-106, 2008.
69. Weisi Y, Yates MZ. Encapsulation and sustained release from biodegradable microcapsules made by emulsification/freeze drying and spray/freeze drying. J Colloid Interf Sci, 336: 155-161, 2009.
70. Schliehe C, Thiry M, Tromsdorf UI, Henthchel J, Weller H, Groettrup M. Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy. J Control Release, 151: 278-285, 2011.
71. Baojun X. Preparation of uniform biodegradable microparticles using laser ablation. Int J Pharm, 325: 194-196, 2006.
72. Jifu M, Shun D, Anna S, Cai Q, Deng X, Yang X. Macroporous and nanofibrous poly (lactide-coglycolide) (50/50) scaffolds via phase separation combined with particle-leaching. Mat Sci Eng C, 32: 1407-1414, 2012.
73. Shuwisitkul D. Biodegradable implants with different drug release profiles. Dissertation submitted to the department of biology, chemistry and pharmacy of Freie University, Berlin; May 2011. Available on line at http://www.diss.fu-berlin.de/diss/receive/FUDISS _thesis_000000023117
74. Felt-Baeyens O, Eperson S, Mora P, Limal D, Sagodira S, Breton P, Simmonazi B, Nobs LB, Crosier G, Gurny R. Biodegradable scleral implants as new triamcinolone acetonide delivery systems. Int J Pharm, 322: 6-12, 2006.
75. Witt C, Mader K, Kissel T. The degradation, swelling and erosion properties of biodegradable implants prepared by extrusion or compression moulding of poly (lactide-co-glycolide) and ABA triblock copolymers. Biomaterials, 21: 931-938, 2000.
76. Mohl S. The Development of a Sustained and Controlled Release Device for pharmaceutical Proteins based on Lipid Implants. Dissertation submitted to Ludwig-Maximilians-University, Munich; November 2004.
77. Gopferich A. Bioerodible implants with programmable drug release. J Control Release, 44: 271-278, 1997.
78. Iyer SS, Barr WH, Karnes HT. A 'biorelevant' approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant. Int J Pharm, 340: 119-125, 2007.
79. Ma G, Song C, Sun H, Yang J, Leng X. A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs. Contraception, 74:141-147, 2006.
80. Shively MF, Coonts BA, Renner WD, Southard JL, Bennett AT. Physico-chemical characterization of a polymeric injectable implant delivery system. J Control Release, 33: 237-243, 1995.
81. Rothen-weinhold A, Besseghir K, Vuaridel E, Sublet E, Oudry N, Kubel F, Gurny R. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants. Eur J Pharm Biopharm, 48: 113-121, 1999.
82. Kunou N, Ogura Y, Hashizoe M, Honda Y, Hyon SH, Ikada Y. Controlled intraocular delivery of ganciclovir with use of biodegradable scaleral implants in rabbits. J Control Release, 37: 143-150, 1995.
83. Orloff LA, Domb AJ, Teomim D, Fishbein I, Golomb G. Biodegradable implant strategies for inhibition of restenosis. Adv Drug Deliver Rev, 24: 3-9, 1997.
84. Baro M, Sanchez E, Delgado A, Perera A, Evora C. In vitro-in vivo characterization of gentamicin bone implants. J Control Release, 83: 353-364, 2002.
85. Saez V, Hernandez JR, Peniche C. Microsphere as delivery system for the controlled release of peptide and proteins. Biotecnologia Aplicada, 24: 108-116, 2007.
86. Zolnik BS, Leary PE, Burgess DJ. Elevated temperature accelerated release testing of PLGA microspheres. J Control Release, 112: 293-300, 2006.
87. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 3: 1377-1397, 2011.
88. Janoria KG, Mitra AK. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Int J Pharm, 338: 133-141, 2007.
89. Alexis F. Factors affecting the degradation and drugrelease mechanism of poly (lactic acid) and poly(lactic acid)-co-(glycolic acid). Polym Int, 54: 36-46, 2005.
90. Wu XS, Wang N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/ glycolic acid polymers. Part II: Biodegradation. J Biomater Sci Polymer Edition, 12: 21-34, 2001.
91. Graves RA, Pamujula S, Moiseyev R, Freeman T, Bostanian LA, Mandal TK. Effect of different ratios of high and low molecular weight PLGA blend on the characteristics of pentamidine microcapsules. Int J Pharm, 270: 251-282, 2004.
92. Ali SAM, Dohetry PJ, Williams DF. Mechanism of polymer degradation in implantable devices. J Biomedical Med Res, 27: 1409-1418, 1993.
93. Freiberg S, Jhu XX. Polymer microspheres for controlled drug release. Int J Pharm, 282: 1-18, 2004.
94. Witt C, Kissel T. Morphological characterization of microspheres, fillms and implants prepared from poly (lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion? Eur J Pharm Biopharm, 51: 171-181, 2001.
95. Biodegradable polymers: chemistry, degradation and applications. Available on line at: http://www.bioen.utah.edu/faculty/pat/Courses/bi omaterials2006/Degradable%20Materials.ppt (Last accessed on 14 January 2013)
96. Li J, Jiang G, Ding F. The Effect of pH on the polymer degradation and drug release from PLGAmPEG microparticles. J App Polym Sci, 109: 475-482, 2008.
97. Zolnik BS, Burgess DJ. Effect of acidic pH on PLGA microsphere degradation and release. J Control Release, 122: 338-344, 2007.
98. Gopferich A. Mechanism of polymer degradation and erosion. Biomaterials, 17: 103-114, 1996.
99. Drug Eluting stent-Wikipedia. Available online at: http://en.wikipedia.org/wiki/Drug-eluting_stent
100. Muni NI, Califf RM, Foy JR, Boam AB, Zuckerman BD, Kuntz RE, Mass B. Coronary drug-eluting stent development: Issues in trial design. Amer Heart J, 149: 415-433, 2005.
101. Iakovou I. Do the new data on second-generation drug eluting stents provide reassurance on safety, efficacy, even for off-label use? Hospital Chronicles, 1: 141-144, 2010.
102. Alfonso F, Fernandez C. Second-generation drugeluting stents: moving the field forward. J Am Coll Cardiol, 58: 1-4, 2011.
103. Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Zoccai GB. Next-generation drug-eluting stents in coronary artery disease: focus on everolimuseluting stent (Xience V®). Vascular Health and Risk Management, 4: 31-38, 2008.
104. Kukreja N, Onuma Y, Daemen J, Serruys PW. The future of drug-eluting stents. Pharmacol Res, 57: 171-180, 2008.
105. Raval A, Parmar A, Raval A, Bahadur P. Preparation and optimization of media using Pluronic® micelles for solubilization of sirolimus and release from the drug eluting stents. Colloids Surf B: Biointerfaces, 93: 180-187, 2012.
106. Pan CH, Tang JJ, Weng YJ, Wang J, Huang N. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents. J Control Release, 116: 42-29, 2006.
107. Pan CJ, Wang J, Huang N. Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings. Colloids Surf B: Biointerfaces, 77: 155-160, 2010.
108. Pan CJ, Tang JJ, Weng YJ, Wang J, Huang N. Preparation and in vitro release profiles of drugeluting controlled biodegradable polymer coating stents. Colloids Surf B: Biointerfaces, 73: 199-206, 2009.
109. Bege N, Steinmuller SO, Kalinowski M, Reul R, Klaus S, Petersen H, Curdy C, Janek J, Kissel T. Drug eluting stents based on Poly (ethylene carbonate): Optimization of the stent coating process. Eur J Pharm Biopharm, 80: 562-570, 2012.
110. Tokar JL, Benerjee S, Barth BA. Drugeluting/ biodegradable stents. Gastrointestinal Endoscopy, 74: 954-958, 2011.
111. Huang Y, Venkatraman SS, Boey F, Lahti EM, Umashankar PR, Mohanty M, Arumugam S, Khanolkar M, Vaishnav S. In vitro and in vivo performance of a dual drug-eluting stent (DDES). Biomaterials, 31: 4382-4391, 2010.
112. Zhang F, Qian J, Dong L, Ge J. Coronary aneurysm formation following biodegradable polymer drugeluting stent implantation. Int J Cardiology, 160: e8-e9, 2012.
113. Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "realworld" practice. JACC: Cardiovascular Intervention, 4: 303-309, 2009.
114. Boam AB. Drug-eluting stents current approach to review. Available on line at: ttp://www.fda.gov/ohrms/dockets/dockets/03n02 03/03n-0203-ts00010-Boam.ppt (Last accessed 08 January 2013)
115. Byrne RA, Kastrati A, Massberg S, Weiczorek A, Laugwitz KL, Hadamitzky M, Schulz S, Pache J, Fusaro M, Mehilli J. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus-versus sirolimus-eluting stents in patients with coronary artery disease. J Amer College Cardiol, 58: 1325-1331, 2011.
116. Htay T, Liu MW. Drug-eluting stent: a review and update. Vascular Health and Risk Management, 1: 263-276, 2005.
117. Ma X, Oyamada S, Gao F, Wu T, Robich MP, Wu H, Wang X, Buchholz B, McCcarthy S, Gu Z, Bianchi CF, Selke FW, Laham R. Paclitaxel/sirolimus combination coated drugeluting stent: In vitro and in vivo drug release studies. J Pharm Biomed Analysis, 54: 807-811, 2011.
118. Raval A, Parikh J, Engineer C. Dexamethasone eluting biodegradable polymeric matrix coated stent for intravascular drug delivery. Chem Eng, 88: 1479-1484, 2010.
119. Conville CM, Major I, Friend DR, Clark MR, Woolfson AD, Malcolm RK. Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings. J Biomed Mat Res B: App Biomat, 100: 891-895, 2012.
120. Benagiano G, Gabelnick HL. Biodegradable systems for the sustained release of fertility-regulating agents. J Steroid Biochem, 11: 449-455, 1979.
121. Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J, 11: 78-87, 2009.
122. Stroock & Lavan LLP. Non-hormonal vaginal contraceptive, U.S. Patent 2,400,71 (2006)
123. Goldsmith A. Long-acting contraception. Papers presented at the symposium on long-acting contraception. Alexandria, Egypt dated on November 3-4, 1983
124. Darney PD. Hormonal implants: contraception for a new century. Am J Obstet Gynecol, 170: 1536-1543, 1994.
125. Hill Lifecare Ltd. A novel intrauterine device with controlled copper release, WO Patent 2,012,063,262 (2012)
126. Srivastav UK. Controlled-release hormone delivery systems for long-term fertility control: the missing dimension. Current R and D Highlights, 16: 14-18, 1993.
127. Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res, 88: S55-S-66, 2010.
128. Alaee M, Moghadam SH, Sayyar P, Atyabi F, Dinarvand R. Preparation of a reservoir type levonorgestrel delivery system using high molecular weight poly L-lactide. Iranian J Pharm Res, 8: 87-93, 2009.
129. Takeda Chemical Industries Ltd. Pharmaceutical product for application to uterus mucosa. U.S. Patent 6,08,3916 (2000)
130. Nagaraju R, Udupa N, Mathew J, Varma BRR. Clinival efficacy of biodegradable dental implants of tinidazole in periodontitls. Indian J Physiol Pharmacol, 43: 125-128, 1999.
131. Nakao K, Tsuji T. Dental regenerative therapy: Stem cell transplantation and bioengineered tooth replacement. Japanese Dental Sci Rev, 44:70-75, 2008.
132. Link DP, Dolder JV, Jourgens WJFM, Wolke J, Jansen JA. Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. Biomaterials, 27: 4941-4947, 2006.
133. Mendonca G, Mendonca DBS, Aragao FJL, Cooper LF. Advancing dental implant surface technology-from micron to nanotopography. Biomaterials, 29: 3822-3835, 2008.
134. Rosa V, Bona AD, Cavalcanti BN, Eduardo J. Tissue engineering: from research to dental clinics. Dental materials, 28: 341-348, 2012.
135. Baht V, Prasad K, Balaji S, Bhat A. Role of tissue engineering in dentistry. J Indian Academy Dental Specialist, 2: 37-42, 2011.
136. Hacking SA and Khademhosseini A. Applications of microscale technologies for regenerative dentistry. J Dental Res, 88: 409-421, 2009.
137. Yuan Z, Nie H, Wang S, Lee CH, Li A, Fu SY, Zhou H, Chen L, Mao JJ. Biomaterial selection for tooth regeneration. Tissue Eng Part B 2011;17:373-88.
138. Moioli EK, Clark PA, Xin X, Lal S, Mao JJ. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv Drug Deliver Rev, 59: 308-324, 2007.
139. Illum L. Nasal drug delivery-recent developments and future prospects. J Control Release, 161: 254-263, 2012.
140. Alpar HO, Somavarapu S, Atuah KN, Bramwell VW. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv Drug Deliver Rev, 57: 411-430, 2005.
141. Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles for nasal vaccination. Adv Drug Deliver Rev, 61: 140-157, 2009.
142. Vila A, Sanchez A, Evora C, Sorino I, McCallion O, Alonso MJ. PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int J Pharm, 292: 43-52, 2005.
143. Yildiz A, Okyar A, Baktir G, Araman A, Ozsoy Y. Nasal administration of heparin-loaded microspheres based on poly (lactic acid). II Farmaco, 60: 919-924, 2005.
144. Seju U, Kumar A, Sawant KK. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies. Acta Biomaterialia, 7:4169-4176, 2011.
145. Li Y, Jiang HL, Zhu KJ, Liu ZH, Hao YL. Preparation, characterization and nasal delivery of acobrotoxin-loaded poly (lactide-co-glycolide)/ polyanhydride microspheres. J Control Release, 108: 10-20, 2005.
146. Armentano I, Dottori M, Fortunati E, Mattiolli S, Kenny JM. Biodegradable polymer matrix nanocomposites for tissue engineering: A review. Polym Deg Stability, 95: 2126-2146, 2010.
147. Tomihata K, Suzuki M, Oka T, Ikada Y. A new resorbable monofilament suture. Polym Deg Stability, 59: 13-18, 1998.
148. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials, 27: 3413-3431, 2006.
149. Robbe R, George A, Paletta J. Knotless suture-based anchors. Operative Techniques in Sports Medicine, 12: 221-224, 2004.
150. Martina M, Hutmacher DW. Biodegradable polymers applied in tissue engineering research: a review. Polym Int, 56: 145-157, 2007.
151. Lombardi AV, Berend KR, Adams JB. Advancing suture technology: A stitch in time. Seminars in Arthoplasty, 22: 179-181, 2011.
152. Kroeze RJ, Helder MN, Govaert LE, Smit TH. Biodegradable polymers in bone tissue engineering. Materials, 2: 833-856, 2009.
153. Nair LS, Laurencin CT. Polymers as biomaterials for tissue engineering and controlled drug delivery. Adv Biochem Engin/Biotechnol, 102: 47-90, 2006.
154. Makela P, Pohjonen T, Tormala P, Waris T, Ashammakhi N. Strength retention properties of self-reinforced poly l-lactide (SR-PLLA) sutures compared with polyglyconate (MaxonR) and polydioxanone (PDS) sutures. An in vitro study. Biomaterials, 23: 2587-2592, 2002.
155. Gunatillake PA and Adhikari R. Biodegradab;le synthetic polymes for tissue engineering. Eur Cells Mat, 5: 1-16, 2003.
156. Yarlagadda P, Chandrasekharan M, Shyam JYM. Recent advances and current developments in tissue scaffolding. Bio-Medical Mat Eng, 15: 159-177, 2005.
157. Dash TK and Konkimalla B. Poly-j{cyrillic, ukrainian}-caprolactone based formulations for drug delivery and tissue engineering: A review. J Control Release, 158: 15-33, 2012.
158. Mano JF, Sousa RA, Boesel LF, Neves NM, Reis RL. Bio inert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: state of the art and recent developments. Composites Sci Technol, 64: 789-817, 2004.
159. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release, 104: 51-66, 2005.
160. Casalini T, Masi M, Perale G. Drug eluting sutures: A model for in vivo estimations. Int J Pharm, 429: 148-157, 2012.
161. Morizumi S. Inhibition of neointimal hyperplasia with a novel tacrolimus-eluting suture. J Am College Cardiology, 58: 441-444, 2011.
162. Gogolewski S. Bioresorbable polymers in trauma and bone surgery. Int J Care Injured, 31: 28-32, 2000.
163. Vieira AC, Guedes RM, Marques AT. Development of ligament tissue biodegradable devices: A review. J Biomechanics, 42: 2421-2430, 2009.
164. Elmi A, Kajbafzadeh AM, Sadeghi Z, Tanhaeivash R, Mirzadeh H. Biodegradable mini plate and screw: A secure method for internal fixation of symphysis pubis in animal model of pubic diastasis. Paediatric Urology, 75: 676-683, 2010.
165. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 21: 2335-2346, 2000.
166. Rokkanen PU, Bostman O, Hirvensalo E, Makela A, Partio EK, Patiala H, Vainionppa S, Vihtonen K, Tormala P. Bioabsorbable fixation in orthopaedic surgery and traumatology. Biomaterials, 21: 2607-2613, 2000.
167. Rangdal S, Singh D, Joshi N, Soni A, Sament R. Functional outcome of ankle fracture patients treated with biodegradable implants. Food and ankle surgery, 18: 153-156, 2012.
168. Enislidis G, Yerit K, Wittwer G, Kohnke R, Schragl S, Ewers R. Self-reinforced biodegradable plates and screws for fixation of zygomatic fractures. J Cranio-Maxillofac Surg, 33: 95-102, 2005.
169. Tasca RA, Sherman IW, Wood GD. Thyroid cartilage fracture: Treatment with biodegradable plates. British J Oral Maxillofac Surg, 46: 159-160, 2008.
170. Kyriakou S, Parara E, Papadogeorgakis N, Christopoulos P, Perisanides C, Dimtas S, Alexendridis K. Use of resorbable plates for traumology of facial skeleton-3 years review. Int J Oral Maxillofac Surg, 34: S1-S181, 2005.
171. Merkli A, Tabatabay C, Gurny R, Heller J. Biodegradable polymers for the controlled release of ocular drugs. Prog Polym Sci, 23: 563-580, 1998.
172. Choonara YE, Pillay V, Carmichael T, Danckwerts MP. An in vitro study of the design and development of a novel doughnut-shaped mini tablet for intraocular implantation. Int J Pharm, 310: 15-24, 2006.
173. Sharma K, Singh V, Arora A. Natural biodegradable polymers as matrices in transdermal drug delivery. Int J Drug Dev Res, 3: 85-103, 2011.
174. Miyazaki S, Takahashi A, Kubo W. Poly nbutylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharmaceut Sci, 6: 240-245, 2003.
175. Kun N, Lee KH, Lee DH, Bae YH. Biodegradable thermo-sensitive nanoparticles from poly (L-lactic acid)/ poly (ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier. Eur J Pharm Sci, 27: 115-122, 2006.
176. Buske J, Konig C, Bassarab S, et al., Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. Eur J Pharm BioPharm, 81: 57-63, 2012.
177. Diou O, Tsapis N, Giraudeau C. Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI. Biomaterials, 33: 5593-5602, 2012.
178. Jin C, Yang W, Bai L, Wang X. Preparation and characterization of targeted DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 for treatment of hepatocellular carcinoma. J Control Release, 152: 14-15, 2011.
179. Li F, Sun J, Zhu H, Wen X. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Colloids Surf B: Biointerfaces, 88: 58-62, 2011.
180. Parveen S and Sahoo SK. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur J Pharmacol, 670: 372-383, 2011.
181. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Medical Devices, 1: 115-125, 2004.
182. Luten J, Van Nostrum CF, Smedt SCD, Hennink WE. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J Control Release, 126: 97-110, 2008.
183. Ahn CH, Chae AY, Bae YH, Kim SW., Synthesis of biodegradable multi-block copolymers of poly (Llysine) and poly (ethylene glycol) as a non-viral gene carrier. J Control Release, 97: 567-574, 2004.
184. Benfer M, Kissel T. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles. Eur J Pharm Biopharm, 80: 247-256, 2012.
185. Lewis KJ, Irwin WJ, Akhtar S. Biodegradable poly (L-lactic acid) matrices for the sustained delivery of antisense oligonucleotides. J Control Release, 37: 173-183, 1995.
186. Choi SH, Park TG. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-inwater emulsion method. Int J Pharm, 311: 223-228, 2006.
187. Chen DW, Hsu YH, Liao JY., Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes. Int J Pharm, 430, 335-341, 2012.
188. Tran VT, Karam JP, Garric X. Protein-loaded PLGA-PEG-PLGA microspheres: A tool for cell therapy. Eur J Pharm Sci, 45: 128-137, 2012.
189. Wang M, Feng O, Guo X, et al. A dual microsphere based on PLGA and chitosan for delivering the oligopeptide derived from BMP-2. Polym Deg Stability, 96: 107-113, 2011.
190. Cun D, Foged C, Yang M. Preparation and characterization of poly (DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm, 390: 70-75, 2010.
191. Tang J, Chen JY, Liu J, et al., Calcium phosphate embedded PLGA nanoparticles: A promising gene delivery vector with high gene loading and transfection efficiency. Int J Pharm, 431: 210-211, 2012.
192. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliver Rev, 55: 329-347, 2003.
193. Oster CG, Wittmar M, Bakowsky U, Kissel T. DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. J Control Release, 111: 371-381, 2006.
194. Zeng P, Xu Y, Zeng C., Chitosan-modified poly (D, L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Int J Pharm, 415: 259-266, 2011.
195. Yan Q, Major TC, Bartlett RH, Meyerhoff ME., Intravascular glucose/lactate sensors prepared with nitric oxide releasing poly (lactide-co-glycolide)-based coatings for enhanced biocompatibility. Biosens Bioelectron, 26: 4276-4282, 2011.
196. Fay F, Quinn DJ, Gilmore BF, et al., Gene delivery using dimethyldidodecyl ammonium bromide-coated PLGA nanoparticles. Biomaterials, 31: 4214-4222, 2010.
197. Mayo AS, Ambati BK, Kompella UB. Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions. Int J Pharm, 387: 278-285, 2010.
198. Nastaran NV and Reza A. An approach to the design of a particulate system for oral protein delivery II. Preparation and stability study of rhGHloaded microspheres in simulated gastrointestinal fluids. Iranian J Pharm Res, 10: 183-192, 2011.
199. Astayeh R, Moghimi HR, Erfan M, Mobedi H. Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behaviour. Daaru, 14: 65-70, 2006.
200. Pareta R and Edirisinghe MJ. A novel method for the preparation of biodegradable microspheres for protein drug delivery. J R Soc Interface, 3: 573-582, 2006.
201. Slutter B, Bal S, Keijzer C, et al., Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: Nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen. Vaccine, 28: 6282-6291, 2010.
202. Sivakumar SM, Sukumaran N, Nirmala L. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant. J Microbiol Immunol Infec, 43: 265-270, 2010.
203. Salvador A, Igartua M, Hernandez AM, Pedraz JL. Combination of immune stimulating adjuvants with poly (lactide-co-glycolide) microspheres enhances the immune response of vaccines. Vaccine, 30: 589-596, 2012.
204. Srinivas M, Cruz LJ, Bonetto F., Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials, 31: 7070-7077, 2010.
205. Tshikhudo N, Pretorius A, Putterill J, Kleef MV. Preparation and in vitro characterisation of Ehrlichia ruminantium plasmid DNA and proteins encapsulated into and DNA adsorbed onto biodegradable microparticles. Ticks and Tick-borne Diseases, 1: 186-193, 2010.
206. Yang Y, Kuang Y, Liu Y. Immunogenicity of multiple-epitope antigen gene of HCV carried by novel biodegradable polymers. Comp Immunol Microbiol Infec Disease, 34: 65-72, 2011.
207. Winzenburg G, Schmidt C, Fuchs S, Kissel T. Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems. Adv Drug Deliver Rev, 56: 1453-1466, 2004.
208. Walduck AK, Opdebeeck JP, Benson HE, Prankerd R. Biodegradable implants for the delivery of veterinary vaccines: design, manufacture and antibody responses in sheep. J Control Release, 51: 269-280, 1998.
209. Khan MJI, Tucker IG, Opdebeeck JP. Cholesterol and lecithin implants for sustained release of antigen: release and erosion in-vitro, and antibody response in mice. Int J Pharm, 76: 161-170, 1991.
210. Middleton JC and Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials, 21: 2335-2346, 2000.
211. Faisant N, Siepmann J, Richard J, Benoit JP. Mathematical modeling of drug release from bioerodible microparticles: effect of gammairradiation. Eur J Pharm Biopharm, 56: 271-279, 2003.
212. Mohanan D, Gander B, Kundig TM, Johansen P. Encapsulation of antigen in poly (D, L-lactide-coglycolide) microspheres protects from harmful effects of c-irradiation as assessed in mice. Eur J Pharm Biopharm, 80: 274-281, 2012.
213. Lee JS, Chae GS, Khang G. The effect of gamma irradiation on PLGA and release behavior of BCNU from PLGA wafer. Macromol Res, 11: 352-356, 2003.
214. Friess W and Schlapp M. Sterilization of gentamicin containing collagen/PLGA microparticle composites. Eur J Pharm Biopharm, 63: 176-187, 2006.
215. Choi Y, Kim SY, Moon MH, Kim SH, Lee KS, Byun Y. Poly (ethylene glycol)} poly (l-lactide) diblock copolymer prevents aggregation of poly (llactide) microspheres during ethylene oxide gas sterilization. Biomaterials, 22: 995-1004, 2001.
216. Wollersheim O, Zumaque H, Hormes J, Kadereit D, Langen J, Haubling L, Hoessel P, Hoffmann G. Quantitative studies of the radiation chemical behaviour of PMMA and poly (lactides). Nucl Instrum Methods Phys Res Sec B, 97: 273-278, 1995.
217. Montanari L, Cilurzo F, Valvo L, Faucitano A, Buttafava A, Groppo A, Genta I, Conti B. Gamma irradiation effects on stability of poly (lactide-coglycolide) microspheres containing clonazepam. J Control Release, 75: 317-330, 2001.
218. Mohr D, Wolff M, Kissel T. Gamma irradiation for terminal sterilization of 17b-estradiol loaded poly-(d, l-lactide-co-glycolide) microparticles. J Control Release, 61:203-217, 1999.
219. Igartua M, Hernandez RM, Rosas JE, Patarroyo ME, Pedraz JL. c-Irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine. Eur J Pharm Biopharm, 69: 519-526, 2008.
220. Inactive ingredient search for approved drug products. Available on line at: http://www.accessdata.fda.gov/scripts/cder/iig/ind ex.cfm (Last accessed on 14 January 2013).
221. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Release, 90: 261-280, 2003.
222. Sadrieh N. Regulatory considerations for nanomaterial-containing therapeutics. 2009, PQRI Workshop, December 2009
223. Tegnander A, Engebresten L, Bergh K. Activation of the complement system and adverse effects of biodegradable pins of polylactic acid (Biofix) in osteochondritis dissecans. Acta Orthop Scand, 65: 472-475, 1994.
224. Guidance document for testing biodegradable polymer implant device. Available at: http://www.fda.gov/medicaldevices/deviceregulatio nandguidance/guidancedocuments/ucm080265.htm
225. Sahoo SK, Prusty AK. Toxicological and regulatory consideration of pharmaceutically important nanoparticles. J Curr Pharm Res, 3: 8-12, 2010.